Instrument Inactif

Gouvernance Infopia Co.,Ltd Korea S.E.

036220

KR7036220002

Equipement, fournitures et distribution médicale

Cours en clôture Korea S.E.
-	-

08/09/25	Sewon et Polaris AI finalisent l'acquisition de 36,8% du capital de HANDYSOFT	CI
17/06/24	Osang Healthcare Co. Ltd (KOSDAQ:A036220) annonce un rachat d'actions pour 375 657 actions.	CI

Comité Exécutif: Infopia Co.,Ltd

Dirigeant

Fonctions occupéesDepuis

Byung-Yeol Yoo

58 ans

Chief Executive Officer	-
President	-

Cheol-Hun Kang

65 ans

Chief Executive Officer	-
President	-

Mi-Sook Park

52 ans

Chief Operating Officer

Composition du Conseil d'Administration: Infopia Co.,Ltd

Administrateur

ComitésDepuis

Dong-Hyun Lee

65 ans

Chairman

30/03/2023

Sang-Wook Han

64 ans

Audit Committee	28/06/2022
Nominating Committee

Yeo-Min Yoon

57 ans

Audit Committee	11/08/2020
Nominating Committee Chair

Jong-Min Lee

65 ans

Audit Committee

29/03/2024

Byung-Chun Kim

65 ans

Director/Board Member	26/03/2026
Independent Dir/Board Member	26/03/2026

Kyung-Mook Seo

69 ans

Director/Board Member	26/03/2026
Independent Dir/Board Member	26/03/2026

Cheol-Hun Kang

65 ans

Director/Board Member

Jong-Nam Ahn

67 ans

Director/Board Member
Independent Dir/Board Member	11/08/2020

Byung-Yeol Yoo

58 ans

Director/Board Member

Anciens Dirigeants et Administrateurs: Infopia Co.,Ltd

Insider

Fonctions occupées

DepuisJusqu'au

Sang-Hwan Ahn

Director/Board Member	28/06/2022	26/03/2026
Independent Dir/Board Member	28/06/2022	26/03/2026

Seung-Eok Hong

Director/Board Member	-	30/04/2024
Chief Executive Officer	08/02/2021	30/04/2024
President	-	30/04/2024

Byeong-Woo Bae

Chief Executive Officer	03/09/2010	-
Chairman	28/03/2014	15/07/2015

David Wong

Director/Board Member	15/07/2015	-
Independent Dir/Board Member	15/07/2015	-

Kwon Park

Comptroller/Controller/Auditor

15/07/2015

Dong-Hoon Min

Director/Board Member	15/07/2015	-
Independent Dir/Board Member	15/07/2015	-

Yoon-Jae Nam

Director/Board Member

15/07/2015

Bum-Seok Kim

Director/Board Member

15/07/2015

Bong-Eok Lee

Director/Board Member	15/07/2015	-
Chief Executive Officer	15/07/2015	-

Tae-Hyung Kwon

Comptroller/Controller/Auditor

28/03/2014

15/07/2015

Byeong-Gwon Bae

Director/Board Member	28/03/2014	15/07/2015
Chief Operating Officer	03/09/2010	08/02/2011
Corporate Officer/Principal	28/03/2014	15/07/2015

Man-Seok Koh

Director/Board Member	29/03/2012	31/03/2015
Chief Executive Officer	29/03/2012	31/03/2015
Corporate Officer/Principal	03/09/2010	29/11/2012
President	29/11/2012	-

Hun-Soo Lee

Director/Board Member	03/09/2010	31/03/2015
Independent Dir/Board Member	03/09/2010	31/03/2015

Sun-Taek Jang

Comptroller/Controller/Auditor

29/03/2013

Sun-Gi Kim

Director/Board Member	-	-
Corporate Officer/Principal	-	-

Ik-Hyun Kim

Corporate Officer/Principal

Nam-Chun Cho

Director/Board Member

Won-Dong Kim

Chief Tech/Sci/R&D Officer	-	-
Corporate Officer/Principal	-	-

Geuk-Rae Lee

Director/Board Member	-	-
President	-	-

Kyung-Ho Lee

Director/Board Member

Jae-Min Park

Director/Board Member

Young-Bae Park

Comptroller/Controller/Auditor

Eui-Seob Lee

Corporate Officer/Principal

Hwa-Jin Lee

Director/Board Member	-	-
Corporate Officer/Principal	-	-

Sung-Dong Lee

Director/Board Member	03/09/2010	-
Chief Tech/Sci/R&D Officer	29/11/2012	-

Jun-Ho Choi

Comptroller/Controller/Auditor

Kang-Kun Lee

Director/Board Member	-	-
Independent Dir/Board Member	-	-

Jung-Seok Woo

Corporate Officer/Principal

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	11
Femme	1

Dont comité exécutif

Homme	2
Femme	1

Dont Administrateurs

Homme	9
Femme	0

Osang HealthCare Co Ltd est une société basée en Corée dont l'activité principale est la recherche et le développement de dispositifs médicaux de diagnostic in vitro. La société opère à travers trois segments. Le secteur du diagnostic biochimique développe principalement des produits tels que des appareils de mesure de la glycémie, de l'hémoglobine glyquée, du cholestérol, des maladies du foie et des appareils U-healthcare. Le segment de l'immunodiagnostic est principalement engagé dans le développement d'appareils d'immunodiagnostic et de capteurs de mesure. Le segment du diagnostic moléculaire se consacre principalement au développement d'appareils et de réactifs de diagnostic moléculaire.

Employés

Secteur

Equipement, fournitures et distribution médicale

Plus d'informations sur la société